Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 709377Generated: October 29, 2026

Farnesyl acetone → (6R,10R)-6,10,14-trimethylpentadecan-2-one

https://huagongshe.com/reaction/709377

Reaction equation

Participants

RoleNameHCIDCharge
ReactantFarnesyl acetoneHCID 1711945—
Reactant(6S,10S)-6,10,14-trimethylpentadecan-2-oneHCID 1810797—
Product(6R,10R)-6,10,14-trimethylpentadecan-2-oneHCID 1810793—
Product(6R,10S)-6,10,14-trimethylpentadecan-2-oneHCID 1810794—
Product(6S,10R)-6,10,14-trimethylpentadecan-2-oneHCID 1810796—
Product(6S,10S)-6,10,14-trimethylpentadecan-2-oneHCID 1810797—

Reaction Steps

Specifically, it has been found that using the R-isomer of catalyst of formula (I) in the hydrogenation of E,E-farnesylacetone (=(5E,9E)-6,10,14-trimethylpentadeca-5,9,13-trien-2-one) the hydrogenation product (6S,10S)-6,10,14-trimethylpentadecan-2-one is formed in more than 96% in respect to all of the possible stereoisomers (i.e. (6S,10S)-6,10,14-trimethylpentadecan-2-one, (6S,10R)-6,10,14-trimethylpentadecan-2-one, (6R,10S)-6,10,14-trimethylpentadecan-2-one and (6R,10R)-6,10,14-trimethylpentadecan-2-one). Hence, the corresponding (6S,10R)- and (6R,10S)- and (6R,10R)-isomers are only formed only in smaller amounts.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS09181163B2
Source datasetuspto-grants-2015_11
ORD IDord-484ef40a30bf43fcbcd378750d863e41
Source noteuspto-grants-2015_11